Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,915 public trials 501 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

The VIBLOK SAfety and perFormancE Trial

NCT03080961

Conditions
Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +15 more
Locations
  • EB FlevoResearch Almere Stad, Flevoland, Netherlands
  • PT&R Beek, Limburg, Netherlands
  • EB UtrechtResearch Utrecht, Netherlands
View Trial Details
Completed

A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV

NCT02751996

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Spring Bank Pharma Research site Calgary, Alberta, Canada
  • Spring Bank Pharma Research site Vancouver, British Columbia, Canada
  • Spring Bank Pharma Research Site London, Ontario, Canada
  • Spring Bank Pharma Research site Toronto, Ontario, Canada
View all 17 locations
View Trial Details
Completed

Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria

NCT04264312

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Xicheng District Center for Disease Prevention and Control Beijing, Beijing Municipality, China
  • Huairou District Center for Disease Prevention and Control Beijing, Beijing Municipality, China
  • Daxing District Center for Disease Prevention and Control Beijing, Beijing Municipality, China
  • Chaoyang District Center for Disease Control and Prevention Beijing, Beijing Municipality, China
View Trial Details
Completed

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT01207388

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • 1102 - LKH Graz Graz, Austria
  • 1107 - Krankenhaus der Elisabethinen Linz, Austria
  • 1106 Salzburg, Austria
  • 1101 - AKH Wien Vienna, Austria
View all 75 locations
View Trial Details
Completed

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

NCT00040846

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +164 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details

Related conditions